PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12943206

Cornelia de Lange syndrome: a case study.

Melanie Benson
View original source ↗Export metadata ↓

Abstract

Cornelia de Lange syndrome (CdLS) is a rare dysmorphogenic disorder characterized by growth retardation, severe cognitive limitations, distinctive facial features, and limb reduction anomalies recognizable at birth. Currently, no single criterion is diagnostic for CdLS, and misdiagnosis is not uncommon. Long-term management of the infant with CdLS requires a coordinated effort among many different specialists. This article presents a general overview of Cornelia de Lange syndrome. It concludes with a case study illustrating the many problems infants with CdLS may have and the great amount of teaching and support that is needed by families affected by CdLS.

Explore related subjects

Chromosomes, Human, Pair 3De Lange SyndromeFemaleHumansInfantTime FactorsTreatment OutcomeCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Melanie Benson. 2002. Cornelia de Lange syndrome: a case study.. https://doi.org/10.1891/0730-0832.21.3.7

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Genes for diabetic nephropathy: sweet prospects on the horizon.

Familial aggregation of diabetic nephropathy has suggested an important role for hereditary factors in the development of this trait. Osterholm et al. provide further evidence that a gene on chromosome 3q confers susceptibility to this diabetic complication.

Chromosomes, Human, Pair 3↗
PubMed2006

Second hit deletion size in von Hippel-Lindau disease.

von Hippel-Lindau (VHL) disease is caused by germline mutations of the VHL tumor suppressor gene. Affected individuals are predisposed to development of multiple neoplastic and preneoplastic lesions of different organs. A "second hit," which is usually represented by deletion in the wild-type VHL allele at 3p25, is necessary for initiation of tumor formation. The impact of the size of this deletion is thought to be critical, because other tumor suppressor genes are located nearby, but this has not yet been studied in detail. We mapped the deletion size of the "second hit" in microdissected tissue from 16 different VHL-associated lesions from the same patient using 10 polymorphic chromosome 3 markers. We found that the deletion size is highly variable, ranging from short deletions around the VHL gene to complete loss of the chromosome 3. The deletion sizes are not correlated with the site of the germline mutation, the affected organ, or the type or biological behavior of the tumor. Even preneoplastic cystic structures may harbor entire loss of the chromosome 3, suggesting that loss of VHL gene function alone is not immediately causative for neoplastic growth, but further events, either mutations and deletions in other chromosomes or epigenetic or other than genetic phenomena, are required for tumor formation.

Chromosomes, Human, Pair 3↗